Top

Published in:

Open Access 01-12-2022 | Research

Association between bone mineral metabolism and vascular calcification in end-stage renal disease

Authors: Louise Aaltonen, Niina Koivuviita, Marko Seppänen, Heikki Kröger, Xiaoyu Tong, Eliisa Löyttyniemi, Kaj Metsärinne

Published in: BMC Nephrology | Issue 1/2022

Abstract

Background

Development of vascular calcification is accelerated in patients with end-stage renal disease. In addition to traditional risk factors of cardiovascular disease (CVD) abnormal bone and mineral metabolism together with many other factors contribute to the excess cardiovascular burden in patients on dialysis. Aortic calcification score and coronary calcification score are predictive of CVD and mortality. The aim of this study was to evaluate the possible relationship between arterial calcification and bone metabolism.

Methods

Thirty two patients on dialysis were included. All patients underwent a bone biopsy to assess bone histomorphometry and a ¹⁸F-NaF PET scan. Fluoride activity was measured in the lumbar spine (L1 – L4) and at the anterior iliac crest. Arterial calcification scores were assessed by computerized tomography for quantification of coronary artery calcification score and lateral lumbar radiography for aortic calcification score.

Results

This study group showed high prevalence of arterial calcification and 59% had verified CVD. Both CAC and AAC were significantly higher in patients with verified CVD. Only 22% had low turnover bone disease. There was a weak association between fluoride activity, which reflects bone turnover, measured in the lumbar spine, and CAC and between PTH and CAC. There was also a weak association between erosion surfaces and AAC. No significant association was found between calcification score and any other parameter measured.

Conclusions

The results in this study highlight the complexity, when evaluating the link between bone remodeling and vascular calcification in patients with multiple comorbidities and extensive atherosclerosis. Several studies suggest an impact of bone turnover on development of arterial calcification and there is some evidence of reduced progression of vascular calcification with improvement in bone status. The present study indicates an association between vascular calcification and bone turnover, even though many parameters of bone turnover failed to show significance. In the presence of multiple other factors contributing to the development of calcification, the impact of bone remodeling might be diminished.

Trial registration

The study is registered in ClinicalTrials.gov protocol registration and result system, ID is NCT02967042. Date of registration is 17/11/2016.

Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F. The cardiovascular burden in end-stage renal disease. Contrib Nephrol. 2017;191:44–57. https://doi.org/10.1159/000479250.CrossRefPubMed

Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380(9854):1649–61. https://doi.org/10.1016/S0140-6736(12)61272-0.CrossRefPubMedPubMedCentral

Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662–73. https://doi.org/10.1016/S0140-6736(12)61350-6.CrossRefPubMedPubMedCentral

Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44(6):1024–30.CrossRef

Tomiyama C, Higa A, Dalboni MA, et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006;21(9):2464–71.CrossRef

Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47. https://doi.org/10.1161/01.cir.97.18.1837.CrossRefPubMed

Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15(7):1014–21. https://doi.org/10.1093/ndt/15.7.1014.CrossRefPubMed

Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648–58. https://doi.org/10.1046/j.1523-1755.1999.00273.x.CrossRefPubMed

Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132(2):245–50.CrossRef

10.

Wilson PW, Kauppila LI, O'Donnell CJ, et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 2001;103(11):1529–34. https://doi.org/10.1161/01.cir.103.11.1529.CrossRefPubMed

11.

van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation. 2004;109(9):1089–94. https://doi.org/10.1161/01.CIR.0000120708.59903.1B.CrossRefPubMed

12.

Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938–42. https://doi.org/10.1161/hy1001.096358.CrossRefPubMed

13.

London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–40. https://doi.org/10.1093/ndt/gfg414.CrossRefPubMed

14.

Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007;49(3):417–25.CrossRef

15.

Cho A, Jung HY, Park HC, Oh J, Kim J, Lee YK. Relationship between abdominal aortic calcification on plain radiograph and coronary artery calcification detected by computed tomography in hemodialysis patients. Clin Nephrol. 2020;93(3):123–9. https://doi.org/10.5414/CN109988.CrossRefPubMed

16.

Peeters MJ, van den Brand JA, van Zuilen AD, et al. Abdominal aortic calcification in patients with CKD. J Nephrol. 2017;30(1):109–18. https://doi.org/10.1007/s40620-015-0260-7.CrossRefPubMed

17.

Zweig BM, Sheth M, Simpson S, Al-Mallah MH. Association of abdominal aortic calcium with coronary artery calcium and obstructive coronary artery disease: a pilot study. Int J Card Imaging. 2012;28(2):399–404. https://doi.org/10.1007/s10554-011-9818-1.CrossRef

18.

Bellasi A, Ferramosca E, Muntner P, et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006;70(9):1623–8.CrossRef

19.

Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG. Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol. 2009;4(1):119–27. https://doi.org/10.2215/CJN.03410708.CrossRefPubMedPubMedCentral

20.

Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27(3):394–401.CrossRef

21.

Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–83. https://doi.org/10.1056/NEJM200005183422003.CrossRefPubMed

22.

Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635–43. https://doi.org/10.1001/jamacardio.2017.0363.CrossRefPubMedPubMedCentral

23.

Thompson GR, Forbat S, Underwood R. Electron-beam CT scanning for detection of coronary calcification and prediction of coronary heart disease. QJM. 1996;89(8):565–70. https://doi.org/10.1093/qjmed/89.8.565.CrossRefPubMed

24.

Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999;74(3):243–52.CrossRef

25.

Barreto DV, Barreto Fde C, Carvalho AB, et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis. 2008;52(6):1139–50. https://doi.org/10.1053/j.ajkd.2008.06.024.CrossRefPubMed

26.

London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004;15(7):1943–51. https://doi.org/10.1097/01.asn.0000129337.50739.48.CrossRefPubMed

27.

London GM, Marchais SJ, Guerin AP, Boutouyrie P, Metivier F, de Vernejoul MC. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol. 2008;19(9):1827–35. https://doi.org/10.1681/ASN.2007050622.CrossRefPubMedPubMedCentral

28.

Aleksova J, Kurniawan S, Vucak-Dzumhur M, et al. Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone. 2018;113:118–23.CrossRef

29.

Chertow GM, Burke SK, Raggi P. Treat to goal working group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245–52.CrossRef

30.

Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815–24.CrossRef

31.

Al-Beyatti Y, Siddique M, Frost ML, Fogelman I, Blake GM. Precision of (1)(8)F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. Osteoporos Int. 2012;23(10):2535–41. https://doi.org/10.1007/s00198-011-1889-2.CrossRefPubMed

32.

Even-Sapir E. (1)(8)F-fluoride PET/computed tomography imaging. PET Clin. 2014;9(3):277–85. https://doi.org/10.1016/j.cpet.2014.03.003.CrossRefPubMed

33.

Frost ML, Compston JE, Goldsmith D, et al. (18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease. Calcif Tissue Int. 2013;93(5):436–47. https://doi.org/10.1007/s00223-013-9778-7.CrossRefPubMedPubMedCentral

34.

Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I. Imaging of site specific bone turnover in osteoporosis using positron emission tomography. Curr Osteoporos Rep. 2014;12(4):475–85. https://doi.org/10.1007/s11914-014-0231-2.CrossRefPubMed

35.

Aaltonen L, Koivuviita N, Seppanen M, et al. Correlation between (18)F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients. Bone. 2020;134:115267.CrossRef

36.

Aaltonen L, Koivuviita N, Seppanen M, et al. Bone histomorphometry and (18)F-sodium fluoride positron emission tomography imaging: comparison between only bone turnover-based and unified TMV-based classification of renal osteodystrophy. Calcif Tissue Int. 2021;109(6):605–14. https://doi.org/10.1007/s00223-021-00874-9.CrossRefPubMedPubMedCentral

37.

Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.CrossRef

38.

Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41. https://doi.org/10.1002/jbmr.5650090802.CrossRefPubMed

39.

Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 2013;28(1):2–17. https://doi.org/10.1002/jbmr.1805.CrossRefPubMed

40.

Recker RR, Akhter MP, Lappe JM, Watson P. Bone histomorphometry in transiliac biopsies from 48 normal, healthy men. Bone. 2018;111:109–15.CrossRef

41.

Recker RR, Lappe JM, Davies M, Kimmel D. Perimenopausal bone histomorphometry before and after menopause. Bone. 2018;108:55–61.CrossRef

42.

Cook GJ, Lodge MA, Marsden PK, Dynes A, Fogelman I. Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med. 1999;26(11):1424–9.CrossRef

43.

Thie JA. Clarification of a fractional uptake concept. J Nucl Med. 1995;36(4):711–2.PubMed

44.

Mace ML, Gravesen E, Nordholm A, et al. Chronic kidney disease-induced vascular calcification impairs bone metabolism. J Bone Miner Res. 2021;36(3):510–22. https://doi.org/10.1002/jbmr.4203.CrossRefPubMed

45.

Asci G, Ok E, Savas R, et al. The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transplant. 2011;26(3):1010–5. https://doi.org/10.1093/ndt/gfq491.CrossRefPubMed

46.

Salam S, Gallagher O, Gossiel F, Paggiosi M, Eastell R, Khwaja A. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease. Bone. 2021;143:115699.CrossRef

47.

Barreto DV, Barreto FC, Carvalho AB, et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005;67(4):1576–82.CrossRef

48.

Coen G, Ballanti P, Mantella D, et al. Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT study. Am J Nephrol. 2009;29(3):145–52. https://doi.org/10.1159/000151769.CrossRefPubMed

49.

Sprague SM, Bellorin-Font E, Jorgetti V, et al. Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis. 2016;67(4):559–66. https://doi.org/10.1053/j.ajkd.2015.06.023.CrossRefPubMed

50.

Aoki A, Kojima F, Uchida K, Tanaka Y, Nitta K. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic hemodialysis patients. Geriatr Gerontol Int. 2009;9(3):246–52. https://doi.org/10.1111/j.1447-0594.2009.00528.x.CrossRefPubMed

Title: Association between bone mineral metabolism and vascular calcification in end-stage renal disease
Authors: Louise Aaltonen
Niina Koivuviita
Marko Seppänen
Heikki Kröger
Xiaoyu Tong
Eliisa Löyttyniemi
Kaj Metsärinne
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/s12882-021-02652-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association between bone mineral metabolism and vascular calcification in end-stage renal disease

Abstract

Background

Methods

Results

Conclusions

Trial registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

The value of repeat kidney biopsy during an atypical course of membranous nephropathy

Consistency of the estimated target weights and ECW/TBW using BIA after hemodialysis in patients between standing and lying-down positions

RNA-seq analysis of extracellular vesicles from hyperphosphatemia-stimulated endothelial cells provides insight into the mechanism underlying vascular calcification

The mediating effect of sleep quality and fatigue between depression and renal function in nondialysis chronic kidney disease: a cross-sectional study

Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy

Survival and predictors of mortality among chronic kidney disease patients on hemodialysis in Amhara region, Ethiopia, 2021

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page